OraSure Technologies saw the highest growth of 1.49% in patent filings in June and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of OraSure Technologies‘s patent filings and grants. Buy the databook here.
OraSure Technologies has been focused on protecting inventions in United States(US) with three publications in Q2 2024
The United States(US) Patent Office dominates the patent filings with nearly 60% of filings. The United States(US), and European Patent Office(EPO) patent Office are among the top ten patent offices where OraSure Technologies is filings its patents..
Thermo Fisher Scientific could be the strongest competitor for OraSure Technologies
Patents related to Covid-19 and industrial automation lead OraSure Technologies's portfolio
OraSure Technologies has the highest number of patents in Covid-19 followed by, industrial automation. For Covid-19, nearly 50% of patents were filed and no patents were granted in Q2 2024.
Coronavirus disease 2019 (covid-19) related patents lead OraSure Technologies portfolio
OraSure Technologies has highest number of patents in coronavirus disease 2019 (covid-19).
For comprehensive analysis of OraSure Technologies's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.